Effective Treatment of Haemophilus influenzae-Induced Bacterial Conjunctivitis by a Bioadhesive Nanoparticle...

Area of Science:

• Ophthalmology
• Nanotechnology
• Biomaterials Science

Background:

• Ocular drug delivery faces challenges due to rapid tear clearance and blinking, limiting antibiotic residence time.
• Effective treatment of bacterial eye infections requires sustained antibiotic concentrations at the infection site.

Purpose of the Study:

• To develop and evaluate a novel biological adhesion reticulate structure (BNP/CA-PEG) for prolonged ocular antibiotic delivery.
• To assess the adhesion properties, treatment efficacy, and safety of BNP/CA-PEG in an ocular infection model.

Main Methods:

• Fabrication of antibiotic-loaded bioadhesion nanoparticles (BNP/CA) and their conjugation with eight-arm NH2-PEG-NH2 to form BNP/CA-PEG.
• Evaluation of adhesion properties via Schiff base reaction between BNP and PEG.
• Assessment of in vivo treatment efficacy in a rat conjunctivitis model and in vitro cytotoxicity testing.

Main Results:

• BNP/CA-PEG nanoparticles exhibited enhanced adhesion properties compared to non-adhesive nanoparticles.
• The formulation demonstrated significantly improved treatment efficacy in a rat ocular infection model.
• In vivo and in vitro studies confirmed the biocompatibility and biosafety of the BNP/CA-PEG structure.

Conclusions:

• The developed biological adhesion reticulate structure offers a promising approach for extended ocular drug delivery.
• BNP/CA-PEG demonstrates superior efficacy and safety, indicating potential for clinical translation in treating bacterial eye infections.